Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 50

Results For "Patient"

5069 News Found

Crown Bioscience partners with Turbine to accelerate translational oncology research
R&D | April 22, 2026

Crown Bioscience partners with Turbine to accelerate translational oncology research

The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems


New guardian protein mechanism identified in aggressive skin cancer progression
R&D | April 22, 2026

New guardian protein mechanism identified in aggressive skin cancer progression

While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies


US FDA okays Merck's new once-daily HIV pill
Drug Approval | April 22, 2026

US FDA okays Merck's new once-daily HIV pill

The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir


Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
R&D | April 22, 2026

Pfizer unleashes wave of breakthrough cancer data at ASCO 2026

Pharma giant targets new standards of care


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform


Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
Clinical Trials | April 22, 2026

Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease

By cutting pain crises & boosting haemoglobin


Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
Clinical Trials | April 22, 2026

Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion

If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev


Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion
News | April 22, 2026

Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion

A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline


Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks
Hospitals | April 22, 2026

Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks

The programme integrates simulation-based training, expert-led sessions, and case-based discussions